DYN Stock Analysis: Buy, Sell, or Hold?
DYN - Dyne Therapeutics, Inc. Common Stock
$25.18
-0.55 (-2.14%)
▼
5d:
+3.03%
30d:
+15.56%
90d:
+43.48%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 27, 2026
0d
Get Alerted When DYN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DYN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: DYN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: DYN is currently trading at $25.18, which is considered extended relative to its 30-day fair value range of $21.63 to $24.83.
Technical Outlook: Technically, DYN is in a strong uptrend. Immediate support is located at $21.71, while resistance sits at $26.26.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $39.53 (+57.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DYN is in a strong uptrend. Immediate support is located at $21.71, while resistance sits at $26.26.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $39.53 (+57.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$21.63 -
$24.83
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.1%
Protect Your Profits
Holding DYN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 57.0% below Wall St target ($39.53)
Trading Range Analysis
30-Day Trading Range
$21.63 -
$24.83
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$21.71
Resistance Level
$26.26
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.85
Wall Street Target
$39.53
(+57.0%)
Share & Embed Analysis
Last updated: August 03, 2026 3:05 AM ET
Data refreshes hourly during market hours. Next update: 4:05 AM
Data refreshes hourly during market hours. Next update: 4:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DYN showing a specific setup today?
Insider Activity (6 Months)
1
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Jason P Rhodes
SELL
287956 shares
2026-04-22
Jason P Rhodes
SELL
274297 shares
2026-04-21
Jason P Rhodes
SELL
272049 shares
2026-04-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$386 | 43 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 49 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 54 HOLD |
Advanced DYN Option Strategies
Professional options setups generated by AI based on today's DYN price and gamma walls.